Am. Groeger et al., SURVIVAL AFTER SURGICAL-TREATMENT OF RECURRENT PULMONARY METASTASES, European journal of cardio-thoracic surgery, 12(5), 1997, pp. 703-705
Objective: Resection of lung metastases is a generally accepted therap
eutic strategy today. This retrospective study was performed in order
to estimate the value of an aggressive surgical approach in recurrent
metastatic disease of the lung. Methods: The survival rates of 42 pati
ents undergoing repeated resectional treatment for recurrent lung meta
stases (group A) were compared to the outcome of a total of 288 patien
ts after a single surgical intervention for lung metastases (group B).
Survival rates and the relative effects of the various prognostic fac
tors were calculated according to Kaplan-Maier and Mantel-Cox or Wilco
xon test. Histology of the primary tumors in group A consisted of 18 c
arcinomas, 22 sarcomas and two melanomas, in group B the distribution
was 64% carcinoma, 27% sarcoma and 9% melanoma. The mean follow-up per
iod was 88.5 months for group A and 27 months for group B. Results: Th
e overall survival rate for group A was 48% at 5 years and 30% at 10 y
ears, the survival rate for group B was 34% at 5 years. Conclusion: Lo
ng-term survival rates superior to those after single resectional trea
tment for lung metastases encourage an aggressive surgical approach fo
r this disease. (C) 1997 Elsevier Science B.V.